Product Images Mirapex ER

This text seems to be a table showing different medication strengths. The first column shows the strength, while the second and third columns show the specific medication and its format (ERJ or ER). However, the characters in the second and third columns are not readable, so it is not possible to fully understand or use this information.*

Mirapex ER® is a medication available as 30 tablets in an original unit of use container, containing 0.375 mg of pramipexole dihydrochloride extended-release tablets to be taken once daily. It is manufactured by Boehringer Ingelheim and is a strong prescription drug that should not be chewed, crushed or dissolved when ingested. The product contains 0.352 mg of pramipexole dihydrochloride and needs to be stored between 20°C and 25°C in a dry place, away from high humidity. The medication should be kept out of reach of children. The product and trademark are licensed from Madelo Germany. Copyright 2021, Boehringer Ingelheim International GmbH.*

Mirapex ER is a medication that comes in a unit of use container with 30 tablets. It contains pramipexole dihydrochloride extended-release tablets of 0.75 mg. It is important to store it in a dry and safe place between 10-25°C (68°F10 77°). The tablets should not be crushed, divided, or chewed but swallowed whole. The product is distributed by Boehringer Ingelheim Pharmaceuticals and it is licensed from Sttt. Overall, it is a prescription medication so it is important to read the accompanying information before use.*

Mirapex ER is a drug that is available in tablet form. The drug's main ingredient is pramipexole dihydrochloride and the tablets are extended-release. The tablets must be swallowed whole and should not be crushed or chewed. It is important to read the prescribing information before taking the medication. Mirapex ER should be stored at a temperature of 20°C to 25°C. The drug is distributed by Boehringer Ingelheim Pharmaceuticals and their trademark is licensed.*

This is a description of a medication called "Mirapex ER" which comes in the form of extended-release tablets. Each tablet contains 102.12mg of pramipexole dihydrochloride monohydrate equivalent. The tablets should be stored at a temperature between 20°C and 25°C and protected from high humidity. The product comes in an original unit of use container. The dosage instructions must be followed as provided in the accompanying prescribing information, and the tablets must be swallowed whole, without being chewed, crushed, or divided. The text also includes a lot number (NOC0597-0286-30) and the name of the manufacturer (Boehringer Ingelheim) and their contact information.*

Strength is expressed as the equivalent of pramipexole dihydrochloride monohydrate of 102.82 mg. Instructions are provided to store at a temperature between 25°C and 120°C (68°F and 77°F) and protect from high humidity. The product is called Mirapex ER and contains extended-release tablets of pramipexole dihydrochloride. The container has a trademark licensed from Boehringer Ingelheim, and it dispenses in an original unit of use container. The text also includes a copyright notice of 2021 to Boehringer Ingelheim Reonty International GmbH.*

Strength of pramipexole dihydrochloride monohydrate is 0.353 mg. The tablets of Mirapex ER should be stored between 20°C to 25°C. They must not be divided, chewed, or crushed, but should be swallowed whole. Dosage information should be read from the prescribing information. This is an extended-release tablet used to treat restless legs syndrome. The product is licensed by Sochunger and is dispensed in the original container. Made in Germany by Boehringer Ingelheim. All rights reserved.*

Mirapex ER is a medication in form of extended-release tablets, with a strength expressed as pramipexole dihydrochloride equivalent to 0.23 mg pramipexole dihydrochloride. The original container of 30 tablets should be used. The tablets should not be chewed, crushed, or divided, but must be swallowed whole. The medication should be stored between 10°C to 25°C (68°F to 77°F) and protected from exposure to high humidity. The accompanying prescription label should be read for dosage instructions. This medication is distributed by Boehringer Ingelheim Pharmaceuticals, Inc. in Ridgefield, CT, and the product and trademark is licensed from an unknown source in Germany.*